Real-World and Clinical Trial Data in Relapsed/Refractory Multiple Myeloma (RRMM): Evaluating Treatment Duration and Comparing Effectiveness and Efficacy

被引：0
|
作者：
Richardson, Paul G.
San Miguel, Jesus F.
Moreau, Philippe
Hajek, Roman
Dimopoulos, Meletios A.
Palumbo, Antonio
Luptakova, Katarina
Skacel, Tomas
Kumar, Shaji K.
Anderson, Kenneth C.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3149
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).
    Krishnan, Amrita Y.
    Nooka, Ajay K.
    Chari, Ajai
    Garfall, Alfred L.
    Martin, Thomas G.
    Nair, Sandhya
    Lin, Xiwu
    Qi, Keqin
    Londhe, Anil
    Pei, Lixia
    Eric, Ammann
    Kobos, Rachel
    Smit, Jennifer
    Parekh, Trilok V.
    Slavcev, Mary
    Usmani, Saad Zafar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
    Terpos, Evangelos
    Ramasamy, Karthik
    Maouche, Nadjoua
    Minarik, Jiri
    Ntanasis-Stathopoulos, Ioannis
    Katodritou, Eirini
    Jenner, Matthew W.
    Plonkova, Hana
    Gavriatopoulou, Maria
    Vallance, Grant D.
    Pika, Tomas
    Kotsopoulou, Maria
    Kothari, Jaimal
    Jelinek, Tomas
    Kastritis, Efstathios
    Aitchison, Robin
    Dimopoulos, Meletios A.
    Zomas, Athanasios
    Hajek, Roman
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (05) : 1049 - 1061
  • [23] Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
    Terpos, Evangelos
    Zambello, Renato
    Leleu, Xavier
    Kuehr, Thomas
    Badelita, Sorina N.
    Katodritou, Eirini
    Brescianini, Alessandra
    Liang, Tony
    Wetten, Sally
    Caers, Jo
    [J]. CANCERS, 2022, 14 (21)
  • [24] Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
    Evangelos Terpos
    Karthik Ramasamy
    Nadjoua Maouche
    Jiri Minarik
    Ioannis Ntanasis-Stathopoulos
    Eirini Katodritou
    Matthew W. Jenner
    Hana Plonkova
    Maria Gavriatopoulou
    Grant D. Vallance
    Tomas Pika
    Maria Kotsopoulou
    Jaimal Kothari
    Tomas Jelinek
    Efstathios Kastritis
    Robin Aitchison
    Meletios A. Dimopoulos
    Athanasios Zomas
    Roman Hajek
    [J]. Annals of Hematology, 2020, 99 : 1049 - 1061
  • [25] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [26] Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia
    Harvanova, L'ubica
    Stulajterova, Viera
    Guman, Tomas
    Ladicka, Miriam
    Hlebaskova, Monika
    Chudej, Juraj
    Simek, Miroslav
    Stecova, Natalia
    Flochova, Emilia
    Kubala, Jan
    Simancikova, Iveta
    Drgona, L'ubos
    Vranovsky, Andrej
    Wild, Alexander
    Mistrik, Martin
    Batorova, Angelika
    [J]. NEOPLASMA, 2021, 68 (03) : 626 - 630
  • [27] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [28] Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
    Salomon-Perzynski, Aleksander
    Walter-Croneck, Adam
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Zielinska, Patrycja
    Wojciechowska, Malgorzata
    Holojda, Jadwiga
    Robak, Pawel
    Pasternak, Anna
    Knopinska-Posluszny, Wanda
    Hawrylecka, Dorota
    Wojtowicz, Marcin
    Szeremet, Agnieszka
    Osowiecki, Michal
    Mordak-Domagala, Monika
    Zaucha, Jan Maciej
    Giannopoulos, Krzysztof
    Warzocha, Krzysztof
    Jamroziak, Krzysztof
    [J]. ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 349 - 355
  • [29] Real World Evaluation of Teclistamab: A Focus on Infections in Patients With Relapsed Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Martin, Thomas
    Wolf, Jeffrey
    Chung, Alfred
    Arora, Shagun
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S536 - S537
  • [30] Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma
    Biran, Noa
    Vesole, David H.
    Zhang, Shijia
    Richter, Joshua R.
    Kuo, Yen-Hong
    Schmidt, Linda
    McBride, Laura
    Anand, Palka
    Ivanovski, Kristin
    Pierre, Amy
    Kumka, Susan
    Cuccurullo, Carmela
    Siegel, David S.
    [J]. BLOOD, 2016, 128 (22)
12345